Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Foluke A. Fasola · Sankore

University of Ibadan

Foluke A. Fasola

ORCID, self-asserted

ORCID 0000-0002-5841-9678

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it. 1 other profile was folded into this one.

Publications

12

Citations

56

h-index

4

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

3

Works published 2022 onward have been swept for this country. Figures are complete within that window, to the extent the open indexes are.

Affiliations

Every institution this scholar has appeared with on a work, by how many.

University of Ibadan14 works
University College Hospital, Ibadan10 works

Publications

12 works in the graph, newest first.

Safety and efficacy of pociredir in adults with severe sickle cell disease and hydroxyurea intolerance or unresponsiveness: results from the phase 1b PIONEER study
2026Journal of sickle cell disease.JournalOpen access0 citations10.1093/jscdis/yoag020.009
The β-goblin gene architecture in individuals with and without sickle cell disease in Nigeria: Implications for β-thalassaemia trait diagnosis
2026African Journal of Laboratory MedicineJournalOpen access0 citations10.4102/ajlm.v15i1.2985
A Phase 1b, Open-label, Multiple-Dose Study Evaluating Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Pociredir in Patients With Sickle Cell Disease (SCD): Trial Design
2025Journal of sickle cell disease.JournalOpen access0 citations10.1093/jscdis/yoaf013.001
Haemoglobin variants in nigeria: real-world data from a point-of-care device
2025Annals of HematologyJournalOpen access1 citations10.1007/s00277-025-06650-1

Efficacy and safety of osivelotor in participants with sickle cell disease in a 12-week phase 2, multicenter, open-label, dose-finding trial and extension study

2025Journal of sickle cell disease.JournalOpen access1 citations10.1093/jscdis/yoag020.001

Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia

2024Nature GeneticsJournalOpen access24 citations10.1038/s41588-024-01929-x

HYPERTENSION AND DIABETES MELLITUS ARE ASSOCIATED WITH DEEP VENOUS THROMBOEMBOLISM: A CASE CONTROL STUDY.

2024PubMedJournalOpen access1 citations

Rh Blood Group Antigens and Alloimmunization Risk of Pregnant Women in South Western, Nigeria.

2024PubMedJournalFirst author0 citations

Blood donation among women in Nigeria: Motivators, barriers and appealing incentives

2023Vox SanguinisJournal10 citations10.1111/vox.13436

Prevalence of hepatitis B virus core antibodies among blood donors in Nigeria: Implications for blood safety

2022African Journal of Laboratory MedicineJournalOpen accessFirst author15 citations10.4102/ajlm.v11i1.1434

Correlates of transfusion transmissible infections among patients with sickle cell disease in Nigeria: case-control study

2022Journal of Immunoassay and ImmunochemistryJournal4 citations10.1080/15321819.2022.2046601

P-060: A HIGHER GRANULOCYTE-LYMPHOCYTE RATIO IS ASSOCIATED WITH IMPROVED RED BLOOD CELL INDICES AND AGE IN DUFFY ANTIGEN-NEGATIVE SICKLE CELL DISEASE PATIENTS.

2022HemaSphereJournalOpen access0 citations10.1097/01.hs9.0000873132.67278.4b